The skills and knowledge you develop at the University of Portsmouth should help you shape the life and career you dream of. So while lectures, seminars and the library are vital, placement opportunities, field trips and access to specialist professional equipment are just as important.
Ranked Gold in the Teaching Excellence Framework and awarded 5 Stars by QS Top Universities 2021, we spoke to Professor Jan Shute, Professor of Respiratory Pharmacology, who offers valuable insight into the workings of the body's immune system and the ways in which University of Portsmouth research is informing the development of effective COVID-19 treatment.
Learn more below, and if you would like to begin your application, arrange a free consultation with SI-UK Pakistan today.
University of Portsmouth COVID-19 Research
"Researchers in my laboratory in the School of Pharmacy and Biomedical Sciences have been investigating an alternative approach to the treatment of airway inflammation, which is based on repurposing heparin, a drug normally used intravenously as an anticoagulant. Heparin is a unique molecule, the most highly negatively charged in biology, with a diverse molecular structure and multiple molecular targets. Our research has identified novel anti-inflammatory and mucus-thinning properties of heparin, effects that are independent of anti-coagulation activity when heparin is inhaled directly into the airways. These observations translated into significant improvements in lung function with the use of inhaled heparin over 21 days of treatment in a clinical trial in patients with moderate to severe COPD.
"Inhaled heparin may therefore represent an effective add-on therapy in COPD and asthma patient groups. In addition, we propose that the multiple pharmacological effects of inhaled heparin are likely to have therapeutic benefit in patients with inflammatory lung disease in SARS-CoV-2 infected patients."
Study at Portsmouth
Begin your application to study at the University of Portsmouth by arranging a free consultation with SI-UK Pakistan today.